P&T Cmtes. Need Incentives To Use Cost-Effectiveness Analyses – MedPAC
Executive Summary
Medicare prescription drug plan pharmacy & therapeutics committees should be given incentives for using cost-effectiveness analyses to develop formularies, Medicare Payment Advisory Commission member Alan Nelson suggested during a March 12 meeting in Washington D.C